Advertisement

Leena Gandhi, MD, PhD, to Lead Lilly Immuno-Oncology


Advertisement
Get Permission

Leena Gandhi, MD, PhD

Leena Gandhi, MD, PhD

Eli Lilly and Company recently announced that Leena Gandhi, MD, PhD, a thoracic oncologist with a focus on immunotherapy and early drug development, will join Lilly Oncology in June 2018 to lead an immuno-oncology medical development. Dr. Gandhi is currently Director of Thoracic Medical Oncology and Associate Professor of Medicine at the New York University School of Medicine.

Dr. Gandhi graduated from NYU School of Medicine and completed her fellowship at Dana-Farber Cancer Institute (DFCI). She worked in the Early Drug Development Center at DFCI and in the Thoracic Oncology Program as the Head of Clinical Trials until 2016, at which point she joined NYU Perlmutter Cancer Center as the Director of Thoracic Medical Oncology.


Advertisement

Advertisement



;
Advertisement